Aeon is scaling multimodal monitoring.
What’s happening: The Zurich-based preventative healthcare startup secured €8.2M ($9.4M) in seed funding led by Concentric. Adding to four sites in Switzerland and Germany, it plans 10 new European clinics, including in the UK.
In check. Cross-checking data from full-body MRIs, blood tests, and DEXA scans in a single visit, Aeon’s AI detects risks for 500+ conditions, including cancer and Alzheimer’s.
Tapping doctors and radiologists to review findings, it claims no false positives in its history and delivers insurer-subsidized checkups, with Swiss provider KPT already onboard.
Rapid care. Pushing prevention, imaging-led health clinics are the new physical.
- Notching 10K scans in Stockholm and London, Neko Health is prepping its first US site.
- Dubai’s DNA Health & Wellness has Saudi Arabia, Oman, and Bahrain on the roadmap.
- Following $120M in funding, Prenuvo is expanding across Europe and Australia while adding brain scans, body comp analysis, and biomarker testing.
Meanwhile, Function Health-owned Ezra is hitting the UK via private clinic Alliance Medical, and medspa resort Clinique La Prairie is testing brain and heart scans in new territories.
Looking ahead: Arming consumers with more clarity, AI-powered diagnostics are shifting the status quo. Emphasizing affordability, Aeon could move the needle where it matters most.
